Fig. 2From: Sodium zirconium cyclosilicate hydrate reduces medical expenses compared with hemodialysis in patients with acute hyperkalemiaComparison of medical expenses between the sodium zirconium cyclosilicate and hemodialysis groups in all patients (A) and patients without complete atrioventricular block (B). Continuous variables are presented as median and interquartile range. *p < 0.05 by Mann–Whitney U-test. HD, hemodialysis; JYN, Japanese yen; and SZC, sodium zirconium cyclosilicateBack to article page